Texas: Uloric (febuxostat) Cardiovascula… | DrugsMonitor.com

Uloric (febuxostat) Cardiovascular Risk litigation (TX) Texas focus: docket-era primer, deadlines, case review—not legal advice.

Litigation has alleged serious injuries tied to this product or device; regulatory actions, science, and defenses vary by claim and time period. This summary is general information only., Texas